Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-024579

President & CEO sold 5,000 shares at $52.14 ($260,700)

  • President & CEO acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Blum Robert I · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $6.67 $33,350 402,456 D
2024-09-30 Sale : show line 2 in the form 10b5-1 −5,000 $52.14 $260,700 397,456 D
Open-market sales · 5,000 sh · avg $52.14 · $260,700

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −5,000 74,727 D
Loading xslF345X05/form4.xml…